Excell Partners

A venture capital firm investing in high-tech, high-growth companies in New York State.

Venture Capital Active Rochester, United States Est. 2005
Last updated 2026-07-20
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$2.0M
total disclosed, rounds participated
Stages
—

About

Excell Partners is a venture capital firm founded in 2005 in partnership with the University of Rochester and Empire State Development (ESD). Its mission is to bridge the gap between breakthrough academic research and commercial viability. Excell invests up to $1.5 million in early-stage rounds and provides hands-on support to high-growth companies. The firm focuses on innovation and aims to generate returns while supporting regional economic development. Excell proactively seeks to support diverse founding teams and underserved communities across New York State.

Portfolio · 1

Lexifone
Automatic In-call Translator
1 round $2.0M committed Latest: 2011-12

Investment activity

Portfolio by sector

Business Software1
Health Tech & Life Sciences1

Q&A

What is Excell Partners' investment focus by sector?
Excell Partners has invested in companies within the Business Software and Health Tech & Life Sciences sectors.
What is Excell Partners' typical investment stage?
Excell Partners primarily invests in A Round funding stages, with two such investments recorded.
Can you name some of Excell Partners' portfolio companies?
Excell Partners' portfolio includes Lexifone, an automatic in-call translator, and Neurogenesis, a company focused on neurodegenerative disease cell therapy.
When did Excell Partners make its most recent investment?
Excell Partners made an investment in March 2022.
What was Excell Partners' earliest recorded investment?
Excell Partners' earliest recorded investment was in December 2011.
What is the typical investment range for Excell Partners?
Excell Partners' investment range is between $2M and $6.66M.
Which company in Excell Partners' portfolio operates in the Health Tech & Life Sciences sector?
Neurogenesis, a company focused on neurodegenerative disease cell therapy, is a portfolio company of Excell Partners in the Health Tech & Life Sciences sector.
Which company in Excell Partners' portfolio operates in the Business Software sector?
Lexifone, an automatic in-call translator, is a portfolio company of Excell Partners in the Business Software sector.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2005